Biosimulation, By Product (Software, In-House Services, Contract Services), By Application (Drug Development, Drug Discovery), By End-User (Contract Research Organizations, Regulatory Authorities, Pharmaceutical and Biotechnology Companies, Academic Research Institutions) and By Region - Global Industry Perspective Comprehensive Analysis and Forecast, 2021-2027


 Request Customization  Sample Request  Ask for Discount
 MDBIECW6G31G  |    May 27, 2020


Biosimulation is computer-aided mathematical simulation biological processes and systems. It is an integral part of systems biology. The complexity involved in biological systems needs simplified models for drug development. The main aim of biosimulation is a model-based prediction methodology in chemicals. The quality of model-based prediction depends on the quality of the sample model. Therefore the data gathered for the biosimulation should be accurate to get the accuracy in the drug development process. Biosimulation technology includes the hardware and software to develop biosimulation models. The major driver for the biosimulation market is the increasing use of pharmacokinetic (PKPD) and pharmacodynamic modeling in clinical research and development. Drug development and drug discovery are major applications for Biosimulation. Increasing investment in healthcare simulation and automation technologies fuel the global demand for biosimulation solutions.



The Biosimulation market is projected to reach $xx.x billion by 2025 from $xx.x billion in 2019 at a CAGR of xx.x%. The Biosimulation market report focuses on demand for the Biosimulation products, the number of clinical trials to develop products, a strategic collaboration between biopharma and contract research organizations to support clinical trials. In addition to this, the report also considered R&D spending by pharma and biotech companies to develop innovative products in Biosimulation market. 

The Biosimulation market research report focuses on detailed analysis of market size, forecasting, demand & supply analysis, price trend analysis, market drivers, restraints, opportunities, market trends, and company market share analysis. 

The Biosimulation market is segmented as below

Biosimulation Segments

The segmental analysis is majorly focuses on the impact of drivers and restraints to derive the final value for Biosimulation market.

Segmentation

Product

  • Software
  • In-House Services
  • Contract Services

Application

  • Drug Development
  • Drug Discovery

End-User

  • Contract Research Organizations
  • Regulatory Authorities
  • Pharmaceutical and Biotechnology Companies
  • Academic Research Institutions

The Biosimulation market report also describes the main players including and how they are strengthening their position in the market with the latest innovations, strategic acquisitions, partnership, and collaboration. It also provides the financial analysis, SWOT analysis, company overview and portfolio analysis of the leading players in the Biosimulation market. 

  • Dassault Systèmes SE
  • Certara USA Inc.
  • Chemical Computing Group
  • Physiomics
  • In Silico Biosciences
  • INOSIM Software
  • Advanced Chemistry Development Inc.
  • Schrodinger Inc.
  • Genedata AG
  • Rhenovia Pharma Ltd



The Biosimulation market report brings market data at one point to understand the Biosimulation market growth trends, market size, and future scenario of the market. This analysis will help the client to plan their expansion, investment, merger acquisition strategy and bring the improvement. All the data of Biosimulation  market is demonstrated in such a way that the end-user can leverage the analyzed data. The analysis includes all segment and sub-segment analysis and their scope, growth rate, market opportunities and challenges. 

The qualitative analysis of Biosimulation market report includes competitive landscape, key growth, and restraining factors. In addition to this, the PESTEL, Porter's Five, and Value chain analysis enables users to understand how the micro and macro-economic factors have influenced the Biosimulation market. The segmental analysis of Biosimulation market report allows users to understand the competitive factors in the market, which help them to take strategic business decisions for sustainable growth. 

Market Density

Market Density is one-stop market research, advisory, consulting and, industry analysis reports platform. The reports' library providing business data and intelligence information on thousands of micro as well as high growth markets with global as well as regional coverage. Market Density offers premium progressive statistical surveying, market research reports, analysis & forecast data for B2B, B2C, and government organizations around the globe. Market Density helps global clients to deal with the business challenges in the competitive world for sustainable growth.

Contact information:

4340 Stevens Creek Blvd,
Suite # 172.
San Jose, CA 95129
Ph : +1 669 264 1656
Email : sales@marketdensity.com

 

  • About Us
    • Why Should you buy this report (sample)
    • How this report delivers? (sample)
    • Key Questions Answered(sample)
  • Chapter 1: Introduction to Biosimulation Market
    • Market Definition
    • Market Segmentation
    • Macro Economic Factor Analysis
  • Chapter 2: Executive Summary
  • Chapter 3: Market Factor Analysis
    • Porter’s Five Forces Analysis
    • PESTEL Analysis
    • Value Chain Analysis
    • SWOT Analysis
    • Pricing Analysis
  • Chapter 4: Global Biosimulation Market Estimation & Forecast By Product
    • Software
    • In-House Services
    • Contract Services
  • Chapter 5: Global Biosimulation Market Estimation & Forecast By Application
    • Drug Development
    • Drug Discovery
  • Chapter 6: Global Biosimulation Market Estimation & Forecast By End-User
    • Contract Research Organizations
    • Regulatory Authorities
    • Pharmaceutical and Biotechnology Companies
    • Academic Research Institutions
  • Chapter 7 Global Biosimulation Market Estimation & Forecast By Region
    • North America
    • Asia Pacific
    • Europe
    • EMEA
    • Latin America
  • Chapter 8 Competitive Landscape
    • Competition Mapping
    • Company Profiles (Suppliers)
      • Dassault Systèmes SE
      • Certara USA Inc.
      • Chemical Computing Group
      • Physiomics
      • In Silico Biosciences
      • INOSIM Software
      • Advanced Chemistry Development Inc.
      • Schrodinger Inc.
      • Genedata AG
      • Rhenovia Pharma Ltd
  • Chapter 9 Recommendations
  • Chapter 10 Acronyms and Assumptions

Purchase options

Single User $ 2100.00
Corporate User $ 3000.00